| Identification | |
|---|---|
| Name | Hexatantalum Dodecabromide |
| Accession Number | DB04119 (EXPT03019) |
| Type | small molecule |
| Description | Not Available |
| Structure |
|
| Categories (*) | |
| Molecular Weight | 2044.535 |
| Groups | experimental |
| Monoisotopic Weight | 2032.70802984 |
| Pharmacology | |
| Indication | Not Available |
| Mechanism of action | Not Available |
| Absorption | Not Available |
| Protein binding | Not Available |
| Biotransformation | Not Available |
| Route of elimination | Not Available |
| Toxicity | Not Available |
| Affected organisms | Not Available |
| Interactions | |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Calcium/calmodulin-dependent protein kinase type II alpha chain | |
|---|---|
| Name | Calcium/calmodulin-dependent protein kinase type II alpha chain |
| Gene Name | CAMK2A |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | 1.0303 |
| Ubiquitin-like modifier-activating enzyme 1 | |
| Name | Ubiquitin-like modifier-activating enzyme 1 |
| Gene Name | UBA1 |
| Pharmacological action | unknown |
| Actions | Not Available |
| References |
|
| DTHybrid score | Not Available |